The DOI matches its OpenAlex record; 49 of the 49 references it cites were found in a registry or an index.
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Abstract
PURPOSE: Insulin, a member of a family of growth factors that includes insulin-like growth factor (IGF)-I and IGF-II, exerts mitogenic effects on normal and malignant breast epithelial cells, acting via insulin and IGF-I receptors. Because of this and because of its recognized association with obesity, an adverse prognostic factor in breast cancer, we examined the prognostic associations of insulin in early-stage breast cancer. PATIENTS AND METHODS: A cohort of 512 women without known diabetes, who had early-stage (T1 to T3, N0 to N1, and M0) breast cancer, was assembled and observed prospectively. Information on traditional prognostic factors and body size was collected, and fasting blood was obtained. RESULTS: Fasting insulin was associated with distant recurrence and death; the hazard ratios and 95% confidence intervals (CI) for those in the highest (> 51.9 pmol/L) versus the lowest (< 27.0 pmol/L) insulin quartile were 2.0 (95% CI, 1.2 to 3.3) and 3.1 (95% CI, 1.7 to 5.7), respectively. There was some evidence to suggest that the association of insulin with breast cancer outcomes may be nonlinear. Insulin was correlated with body mass index (Spearman r = 0.59, P <.001), which, in turn, was associated with distant recurrence and death (P <.001). In multivariate analyses that included fasting insulin and available tumor- and treatment-related variables, adjusted hazard ratios for the upper versus lower insulin quartile were 2.1 (95% CI, 1.2 to 3.6) and 3.3 (95% CI, 1.5 to 7.0) for distant recurrence and death, respectively. CONCLUSION: Fasting insulin level is associated with outcome in women with early breast cancer. High levels of fasting insulin identify women with poor outcomes in whom more effective treatment strategies should be explored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impact of Event Scale: A Measure of Subjective Stress
Horowitz, M., Wilner, N., & Alvarez, W. (1979) · Psychosomatic Medicine · doi:10.1097/00006842-197905000-00004 · Cited by 7,813
Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411501 · Cited by 3,643
A DATA-BASED APPROACH TO DIET QUESTIONNAIRE DESIGN AND TESTING
BLOCK, G., HARTMAN, A. M., DRESSER, C. M., CARROLL, M. D., GANNON, J., & GARDNER, L. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114416 · Cited by 2,163
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,823
Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer
Bonadonna, G., Brusamolino, E., Valagussa, P., Rossi, A., Brugnatelli, L., Brambilla, C., De Lena, M., Tancini, G., Bajetta, E., Musumeci, R., et al. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602192940801 · Cited by 1,329
Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., & Vigneri, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3278 · Cited by 902
Le Roith, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360907 · Cited by 897
Levine, M. N., Bramwell, V. H., Pritchard, K. I., Norris, B. D., Shepherd, L. E., Abu-Zahra, H., Findlay, B., Warr, D., Bowman, D., Myles, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2651 · Cited by 617
Self-citationInsulin resistance and breast‐cancer risk
Bruning, P. F., Bonfrèr, J. M. G., van Noord, P. A. H., Hart, A. A. M., de Jong‐Bakker, M., & Nooijen, W. J. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520402 · Cited by 361
Insulin and related factors in premenopausal breast cancer risk
Del Giudice, M. E., Fantus, I. G., Ezzat, S., McKeown-Eyssen, G., Page, D., & Goodwin, P. J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005831013718 · Cited by 304
Self-citation
Research works printed but not linked: 6
- 10.1002/ijc.2910490409 · doi:10.1002/ijc.2910490409
- 10.1038/bjc.1997.129 · doi:10.1038/bjc.1997.129
- 10.1002/(SICI)1096-9896(199712)183:4<412::AID-PATH944>3.0.CO;2-4 · doi:10.1002/(sici)1096-9896(199712)183:4<412::aid-path944>3.0.co;2-4
- 10.1007/BF00665970 · doi:10.1007/bf00665970
- 10.1177/030089169408000309 · doi:10.1177/030089169408000309
- 10.1016/0960-0760(90)90426-L · doi:10.1016/0960-0760(90)90426-l
Cited by
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Physical activity and survival after breast cancer diagnosis
Holmes, M. D. (2005) · JAMA · doi:10.1001/jama.293.20.2479 · Cited by 1,772
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu042 · Cited by 1,165
The insulin and insulin-like growth factor receptor family in neoplasia: an update
Pollak, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3215 · Cited by 1,116
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation
Iyengar, N. M., Gucalp, A., Dannenberg, A. J., & Hudis, C. A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.4283 · Cited by 1,004
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
DeCensi, A., Puntoni, M., Goodwin, P., Cazzaniga, M., Gennari, A., Bonanni, B., & Gandini, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0157 · Cited by 918
Self-citationPicon‐Ruiz, M., Morata‐Tarifa, C., Valle‐Goffin, J. J., Friedman, E. R., & Slingerland, J. M. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21405 · Cited by 893
Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880
Diabetes mellitus and risk of breast cancer: A meta‐analysis
Larsson, S. C., Mantzoros, C. S., & Wolk, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22717 · Cited by 875
Comprehensive geriatric assessment for older patients with cancer
Extermann, M., & Hurria, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.6559 · Cited by 875
Pi-Sunyer, F. X. (2002) · Obesity Surgery · doi:10.1007/bf03342140 · Cited by 827
Chlebowski, R. T., Blackburn, G. L., Thomson, C. A., Nixon, D. W., Shapiro, A., Hoy, M. K., Goodman, M. T., Giuliano, A. E., Karanja, N., McAndrew, P., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj494 · Cited by 825
Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer
Budd, G. T., Cristofanilli, M., Ellis, M. J., Stopeck, A., Borden, E., Miller, M. C., Matera, J., Repollet, M., Doyle, G. V., Terstappen, L. W. M. M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1769 · Cited by 775
Wolin, K. Y., Carson, K., & Colditz, G. A. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0285 · Cited by 778
Weight Loss in Breast Cancer Patient Management
Chlebowski, R. T., Aiello, E. J., & McTiernan, A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.1128 · Cited by 623
Irwin, M. L., Crumley, D., McTiernan, A., Bernstein, L., Baumgartner, R., Gilliland, F. D., Kriska, A., & Ballard‐Barbash, R. (2003) · Cancer · doi:10.1002/cncr.11227 · Cited by 611
Adiponectin and Breast Cancer Risk
Mantzoros, C., Petridou, E., Dessypris, N., Chavelas, C., Dalamaga, M., Alexe, D. M., Papadiamantis, Y., Markopoulos, C., Spanos, E., Chrousos, G., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031804 · Cited by 533
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
Sparano, J. A., Gray, R. J., Ravdin, P. M., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1904819 · Cited by 532
Self-citationReaven, G. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.002 · Cited by 507
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression
Vona-Davis, L., & Rose, D. P. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-06-0068 · Cited by 496
“2004) and prognosis (Goodwin et al. 2002).”
BackgroundPhysical Activity and Survival after Diagnosis of Invasive Breast Cancer
Holick, C. N., Newcomb, P. A., Trentham-Dietz, A., Titus-Ernstoff, L., Bersch, A. J., Stampfer, M. J., Baron, J. A., Egan, K. M., & Willett, W. C. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0771 · Cited by 491
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Bodmer, M., Meier, C., Krähenbühl, S., Jick, S. S., & Meier, C. R. (2010) · Diabetes Care · doi:10.2337/dc09-1791 · Cited by 466
Morris, P. G., Hudis, C. A., Giri, D., Morrow, M., Falcone, D. J., Zhou, X. K., Du, B., Brogi, E., Crawford, C. B., Kopelovich, L., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0110 · Cited by 465
Pierce, J. P., Stefanick, M. L., Flatt, S. W., Natarajan, L., Sternfeld, B., Madlensky, L., Al-Delaimy, W. K., Thomson, C. A., Kealey, S., Hajek, R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6819 · Cited by 464
Obesity, adipocytokines, and insulin resistance in breast cancer
Rose, D. P., Komninou, D., & Stephenson, G. D. (2004) · Obesity Reviews · doi:10.1111/j.1467-789x.2004.00142.x · Cited by 460
Molecular links between obesity and breast cancer
Lorincz, A. M., & Sukumar, S. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.00729 · Cited by 439
The metabolic syndrome: requiescat in pace
Reaven, G. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.048611 · Cited by 427
Cowey, S., & Hardy, R. W. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051090 · Cited by 431
Diabetes mellitus and breast cancer
Wolf, I., Sadetzki, S., Catane, R., Karasik, A., & Kaufman, B. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)01736-5 · Cited by 422
Nutrition and Survival After the Diagnosis of Breast Cancer: A Review of the Evidence
Rock, C. L., & Demark-Wahnefried, W. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.008 · Cited by 412
Understanding the benefit of metformin use in cancer treatment
Dowling, R. J., Goodwin, P. J., & Stambolic, V. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-33 · Cited by 409
Self-citationObesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities
Jiralerspong, S., & Goodwin, P. J. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.4480 · Cited by 405
Self-citationMetformin: Taking away the candy for cancer?
Jalving, M., Gietema, J. A., Lefrandt, J. D., Jong, S. D., Reyners, A. K. L., Gans, R. O. B., & Vries, E. G. E. D. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.06.012 · Cited by 380
Impact of Diabetes Mellitus on Outcomes in Patients With Colon Cancer
Meyerhardt, J. A., Catalano, P. J., Haller, D. G., Mayer, R. J., Macdonald, J. S., Benson, A. B., & Fuchs, C. S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.125 · Cited by 374
Dieli-Conwright, C. M., Courneya, K. S., Demark-Wahnefried, W., Sami, N., Lee, K., Buchanan, T. A., Spicer, D. V., Tripathy, D., Bernstein, L., & Mortimer, J. E. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.7526 · Cited by 366
Rating the Risk Factors for Breast Cancer
Singletary, S. E. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000059969.64262.87 · Cited by 363
Irwin, M. L., McTiernan, A., Baumgartner, R. N., Baumgartner, K. B., Bernstein, L., Gilliland, F. D., & Ballard-Barbash, R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.036 · Cited by 360
Metformin in cancer: translational challenges
Dowling, R. J. O., Niraula, S., Stambolic, V., & Goodwin, P. J. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0007 · Cited by 355
Self-citationDiabetes, metabolic syndrome, and breast cancer: a review of the current evidence
Xue, F., & Michels, K. B. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.823s · Cited by 353
Palumbo, A., Bringhen, S., Ludwig, H., Dimopoulos, M. A., Bladé, J., Mateos, M. V., Rosiñol, L., Boccadoro, M., Cavo, M., Lokhorst, H., et al. (2011) · Blood · doi:10.1182/blood-2011-06-358812 · Cited by 352
Friedenreich, C. M., & Cust, A. E. (2008) · British Journal of Sports Medicine · doi:10.1136/bjsm.2006.029132 · Cited by 345
Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer
Goodwin, P. J., Ennis, M., Pritchard, K. I., Koo, J., & Hood, N. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.0725 · Cited by 339
Self-citationObesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation
Divella, R., De Luca, R., Abbate, I., Naglieri, E., & Daniele, A. (2016) · Journal of Cancer · doi:10.7150/jca.16884 · Cited by 335
van de Poll‐Franse, L. V., Houterman, S., Janssen‐Heijnen, M. L. G., Dercksen, M. W., Coebergh, J. W. W., & Haak, H. R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22532 · Cited by 324
Disrupting insulin-like growth factor signaling as a potential cancer therapy
Sachdev, D., & Yee, D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0080 · Cited by 320
Obesity and Outcomes in Premenopausal and Postmenopausal Breast Cancer
Loi, S., Milne, R. L., Friedlander, M. L., McCredie, M. R. E., Giles, G. G., Hopper, J. L., & Phillips, K.-A. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0042 · Cited by 319
Disrupting Insulin-Like Growth Factor Signaling as a Potential Cancer Therapy
Sachdev, D., & Yee, D. (2008) · AACR Education book · doi:10.1158/aacr.edb-mct-06-0080 · Cited by 314
Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction
Jones, L. W., Eves, N. D., Haykowsky, M., Freedland, S. J., & Mackey, J. R. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70031-2 · Cited by 309
Meyerhardt, J. A., Catalano, P. J., Haller, D. G., Mayer, R. J., Benson, A. B., Macdonald, J. S., & Fuchs, C. S. (2003) · Cancer · doi:10.1002/cncr.11544 · Cited by 306
Repurposing metformin for the prevention of cancer and cancer recurrence
Heckman-Stoddard, B. M., DeCensi, A., Sahasrabuddhe, V. V., & Ford, L. G. (2017) · Diabetologia · doi:10.1007/s00125-017-4372-6 · Cited by 297
Associations of Insulin Resistance and Adiponectin With Mortality in Women With Breast Cancer
Duggan, C., Irwin, M. L., Xiao, L., Henderson, K. D., Smith, A. W., Baumgartner, R. N., Baumgartner, K. B., Bernstein, L., Ballard-Barbash, R., & McTiernan, A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.4473 · Cited by 294
The Role of Obesity in Cancer Survival and Recurrence
Demark-Wahnefried, W., Platz, E. A., Ligibel, J. A., Blair, C. K., Courneya, K. S., Meyerhardt, J. A., Ganz, P. A., Rock, C. L., Schmitz, K. H., Wadden, T., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0485 · Cited by 290
Self-citationUndertreatment of Obese Women Receiving Breast Cancer Chemotherapy
Griggs, J. J., Sorbero, M. E. S., & Lyman, G. H. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.11.1267 · Cited by 289
Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
Richardson, L. C., & Pollack, L. A. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0062 · Cited by 289
Ligibel, J. A., Campbell, N., Partridge, A., Chen, W. Y., Salinardi, T., Chen, H., Adloff, K., Keshaviah, A., & Winer, E. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7357 · Cited by 289
Insulin–PI3K signalling: an evolutionarily insulated metabolic driver of cancer
Hopkins, B. D., Goncalves, M. D., & Cantley, L. C. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0329-9 · Cited by 288
ERGO: A pilot study of ketogenic diet in recurrent glioblastoma
RIEGER, J., BÄHR, O., MAURER, G. D., HATTINGEN, E., FRANZ, K., BRUCKER, D., WALENTA, S., KÄMMERER, U., COY, J. F., WELLER, M., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2382 · Cited by 287
Flattened cortisol rhythms in metastatic breast cancer patients
Abercrombie, H. C., Giese-Davis, J., Sephton, S., Epel, E. S., Turner-Cobb, J. M., & Spiegel, D. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.11.003 · Cited by 286
Obesity and Cancer: Local and Systemic Mechanisms
Iyengar, N. M., Hudis, C. A., & Dannenberg, A. J. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-050913-022228 · Cited by 281
Irwin, M. L., Varma, K., Alvarez-Reeves, M., Cadmus, L., Wiley, A., Chung, G. G., DiPietro, L., Mayne, S. T., & Yu, H. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0531 · Cited by 279
Adiposity and Sex Hormones in Postmenopausal Breast Cancer Survivors
McTiernan, A., Rajan, K. B., Tworoger, S. S., Irwin, M., Bernstein, L., Baumgartner, R., Gilliland, F., Stanczyk, F. Z., Yasui, Y., & Ballard-Barbash, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.057 · Cited by 278
Gualberto, A., & Pollak, M. (2009) · Oncogene · doi:10.1038/onc.2009.172 · Cited by 274
Park, S. M., Lim, M. K., Shin, S. A., & Yun, Y. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0243 · Cited by 263
Buffart, L. M., Galvão, D. A., Brug, J., Chinapaw, M. J. M., & Newton, R. U. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.06.007 · Cited by 266
Impact of Age, Sex, and Comorbidity on Cancer Therapy and Disease Progression
Pal, S. K., & Hurria, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0579 · Cited by 265
Cancer‐related fatigue: Implications for breast cancer survivors
Berger, A. M., Gerber, L. H., & Mayer, D. K. (2012) · Cancer · doi:10.1002/cncr.27475 · Cited by 264
Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer
Vona‐Davis, L., Howard‐McNatt, M., & Rose, D. P. (2007) · Obesity Reviews · doi:10.1111/j.1467-789x.2007.00396.x · Cited by 263
Obesity and cancer: existing and new hypotheses for a causal connection
Stone, T. W., McPherson, M., & Gail Darlington, L. (2018) · eBioMedicine · doi:10.1016/j.ebiom.2018.02.022 · Cited by 262
Breast Cancer and Obesity: An Update
Stephenson, G. D., & Rose, D. P. (2003) · Nutrition and Cancer · doi:10.1207/s15327914nc4501_1 · Cited by 258
Gallagher, E. J., & LeRoith, D. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0295-5 · Cited by 241
Buckland, G., Travier, N., Cottet, V., González, C. A., Luján‐Barroso, L., Agudo, A., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Peeters, P. H., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27958 · Cited by 238
Wolpin, B. M., Meyerhardt, J. A., Chan, A. T., Ng, K., Chan, J. A., Wu, K., Pollak, M. N., Giovannucci, E. L., & Fuchs, C. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9945 · Cited by 231
Goodwin, P. J., Segal, R. J., Vallis, M., Ligibel, J. A., Pond, G. R., Robidoux, A., Blackburn, G. L., Findlay, B., Gralow, J. R., Mukherjee, S., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.1517 · Cited by 197
Self-citationDiabetes and Cancer: Risk, Challenges, Management and Outcomes
Shahid, R. K., Ahmed, S., Le, D., & Yadav, S. (2021) · Cancers · doi:10.3390/cancers13225735 · Cited by 187
“evaluated insulin levels in 512 nondiabetic women with early-stage breast cancer [64].”
BackgroundBayraktar, S., Hernadez‐Aya, L. F., Lei, X., Meric‐Bernstam, F., Litton, J. K., Hsu, L., Hortobagyi, G. N., & Gonzalez‐Angulo, A. M. (2012) · Cancer · doi:10.1002/cncr.26439 · Cited by 176
The impact of diabetes on survival following breast cancer
Lipscombe, L. L., Goodwin, P. J., Zinman, B., McLaughlin, J. R., & Hux, J. E. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9654-0 · Cited by 176
Outcomes of a weight loss intervention among rural breast cancer survivors
Befort, C. A., Klemp, J. R., Austin, H. L., Perri, M. G., Schmitz, K. H., Sullivan, D. K., & Fabian, C. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1922-3 · Cited by 138
Glucose Promotes Breast Cancer Aggression and Reduces Metformin Efficacy
Wahdan-Alaswad, R., Fan, Z., Edgerton, S. M., Liu, B., Deng, X.-S., Arnadottir, S. S., Richer, J. K., Anderson, S. M., & Thor, A. D. (2013) · Cell Cycle · doi:10.4161/cc.26641 · Cited by 125
Kaaks, R., Bellati, C., Venturelli, E., Rinaldi, S., Secreto, G., Biessy, C., Pala, V, Sieri, S., & Berrino, F. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601647 · Cited by 120
Obesity and breast cancer: A case of inflamed adipose tissue
Kolb, R., & Zhang, W. (2020) · Cancers · doi:10.3390/cancers12061686 · Cited by 119
Dowling, R. J., Niraula, S., Chang, M. C., Done, S. J., Ennis, M., McCready, D. R., Leong, W. L., Escallon, J. M., Reedijk, M., Goodwin, P. J., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0540-0 · Cited by 117
Self-citationThe impact of type 2 diabetes mellitus on cancer‐specific survival: A follow‐up study in sweden
Liu, X., Ji, J., Sundquist, K., Sundquist, J., & Hemminki, K. (2012) · Cancer · doi:10.1002/cncr.26420 · Cited by 97
Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer
Mulligan, A. M., O’Malley, F. P., Ennis, M., Fantus, I. G., & Goodwin, P. J. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9471-x · Cited by 96
Self-citationThomson, C. A., Stopeck, A. T., Bea, J. W., Cussler, E., Nardi, E., Frey, G., & Thompson, P. A. (2010) · Nutrition and Cancer · doi:10.1080/01635581.2010.513803 · Cited by 94
“Furthermore, there is evidence that the macronutrient content of low-fat diets may contribute to obesity-related hyperinsulinemia, an independent risk factor for breast cancer recurrence (25,26).”
BackgroundSerum Lipids and Outcome of Early-stage Breast Cancer: Results of a Prospective Cohort Study
Bahl, M., Ennis, M., Tannock, I. F., Hux, J. E., Pritchard, K. I., Koo, J., & Goodwin, P. J. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-6654-9 · Cited by 80
Self-citationInterval versus continuous aerobic exercise training in breast cancer survivors—a pilot RCT
Dolan, L. B., Campbell, K., Gelmon, K., Neil-Sztramko, S., Holmes, D., & McKenzie, D. C. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-015-2749-y · Cited by 69
Development of Exercise as Interception Therapy for Cancer: A Review
Iyengar, N. M., & Jones, L. W. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.2585 · Cited by 67
Improvement of Metabolism among Obese Breast Cancer Survivors in Differing Weight Loss Regimens
Jen, K. ‐. C., Djuric, Z., DiLaura, N. M., Buison, A., Redd, J. N., Maranci, V., & Hryniuk, W. M. (2004) · Obesity Research · doi:10.1038/oby.2004.38 · Cited by 59
Minding the body: Psychotherapy and cancer survival
Spiegel, D. (2014) · British Journal of Health Psychology · doi:10.1111/bjhp.12061 · Cited by 53
Knobf, M. T., Jeon, S., Smith, B., Harris, L., Thompson, S., Stacy, M. R., Insogna, K., & Sinusas, A. J. (2017) · Heart & Lung · doi:10.1016/j.hrtlng.2017.06.001 · Cited by 26
Metadata
- Authors
- Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-01-01
- Volume
- 20
- Issue
- 1
- Pages
- 42-51
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2099111137
- Cited by
- 981
- References
- 49
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.